In addition, since the activation of the innate immune activation also triggers antigen-specific adaptive immune responses [27], HO-1 activation could potentially enhance the effectiveness of the secondary adaptive or humoral immune response produced naturally in recovered COVID-19 patients as well as in vaccine administered individuals. This evidence concerns the gene HMOX1 and COVID-19.